Table 3: The Values of Lymphocytes at Baseline and After 6 Months of Anti-TNFa Treatment

Cells	ADA Group Week 0	ETN Group Week 0	IFN Group Week 0	Normal Value in Donors Age Matched	P Value	ADA Group Week 24	ETN Group Week 24	IFN Group Week 24	P Value
CD3+	1734±657	1725±688	1724±637	1100-1700	NS	1838±632	1653±736	1645±624	NS
CD3+/CD4+	1734±657	1134±317	1158±366	650-1400	NS	1250±496	1065±562	1067±446	NS
CD3+/CD8+	470±210	445±218	480±205	320-900	NS	520±230	489±223	534±321	NS
CD19+	268±89	245±92	259±91	200-400	NS	273±143	261±202	255±174	NS
CD20+	198±156	191±146	188±126	150-400	NS	193±179	164±85	99±17	NS
CD19+/CD38+	234±143	223±133	214±163	150-400	NS	240±155	109±74	79±15	NS
CD16+/56+	211±72	217±68	213±67	200-400	NS	219±87	211±54	210±45	NS
CD14+HLADR+%	57±12	55±14	59±12	50-90	NS	54.6±10.4	48.4±15.7	40.7±16.5	<0.039
CD14+HLADR+	345±213.	335±223	349±209	300-400	NS	326±214	311±230.	246±78	<0.05